OLIN LURBE GUILLEN: Open Payments
NPI 1023759461 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 67 payments from 15 companies in 2025. Trend: 2023 $1,177 · 2024 $1,006 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $247 |
| Lilly USA, LLC | 13 | $188 |
| AstraZeneca Pharmaceuticals LP | 9 | $179 |
| Amgen Inc. | 11 | $163 |
| PFIZER INC. | 4 | $88 |
| Exact Sciences Corporation | 3 | $81 |
| Abbott Laboratories | 2 | $41 |
| Dexcom, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $28 |
Products named: MOUNJARO, Ozempic, AIRSUPRA, OTEZLA, Wegovy, Cologuard Collection Kit, REPATHA, PAXLOVID.
Industry payments across FL — which companies pay providers there.
